A synthesis of (±) epipentenomycin I and III is reported from a regioselective epoxidation of racemic 3-hydroxy-and 3-acetoxy-2-methylene-4-cyclopentenone, respectively, with dimethyldioxirane followed by hydrolytic ring-opening of the resulting epoxide. Abstract: A synthesis of () epipentenomycin I and III is reported from a regioselective epoxidation of racemic 3-hydroxyand 3-acetoxy-2-methylene-4-cyclopentenone, respectively, with dimethyldioxirane followed by hydrolytic ring-opening of the resulting epoxide.
The pentenomycin group of natural products (compounds 1-4) have antibacterial activities against both Gram-positive and Gram-negative bacteria. Pentenomycin I (1) and II (2) were first isolated from
Streptomyces eurythermus in 1973
1 while pentenomycin III (3) was isolated three years later from Streptoverticillium eurocidicum. 2 Epipentenomycin I (4), however, was isolated in 1989 3 from carpophores of Perziza sp., much later than its first synthesis in racemic form in 1980. 4, 5 Their biological activities and their highly oxygenated structures have attracted several synthetic studies on their total synthesis, 6 the synthesis of their racemates 4, 5, 7 and their analogues 8 (e.g. epipentenomycin II (5) and III (6)). We report here a diastereoselective synthesis of () epipentenomycin I (4) and III (6) from the diastereoselective epoxidation of 3-hydroxy-and 3-acetoxy-2-methylene-4-cyclopentenone, respectively, with dimethyldioxirane followed by hydrolytic ring-opening of the resulting epoxide.
NMR spectra of compound 10 indicated the presence of an ethyl and an acetate group and its structure was unequivocally determined by a single-crystal X-ray study (Fig. 1 While the mechanism for the formation of 10 is not clear, this compound formally arises from the incorporation of one molecule of DMDO into 7 (Scheme 2). Interestingly, both products 8 and 10 arise from addition of DMDO anti to the allylic hydroxyl group in 7. Our attempts to reverse the diastereoselectivity in favour of diastereomer 9, which should yield pentenomycin I after hydrolytic epoxide ring-opening, were unsuccessful. The use of the less polar solvent CCl 4 in this reaction, conditions that should favour 9 by enhancing H-bonding between the allylic hydroxyl group in 7 and DMDO, 13 led to poorer overall yields due to incomplete conversion of 7 and resulted in little changes in the diastereoselectivities. In an attempt to prepare () epipentenomycin II (5) we acetylated the known alcohols rac-11a and rac-11b, to
give their respective allylic acetates, rac-12a and rac-12b These compounds were highly crystalline and their relative stereochemistries were secured by single-crystal X-ray studies.
novel allylic acetate rac-13 in 78% yield. In conclusion we have developed a synthesis of epipentenomycin I via a diastereoselective epoxidation of 7
followed by mild hydrolysis of the resulting epoxide group. We have also found a novel oxidation product, the compound 10, in this epoxidation reaction. We are currently working on the synthesis of enantiomerically pure 7 to allow the preparation of enantiomerically pure pentenomycins and their derivatives. 
